Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
BroadOak Capital Partners is a boutique investment bank and private equity firm focused exclusively on the life science tools, diagnostics, and services sectors. The firm provides capital and advisory services to companies involved in research tools, clinical diagnostics, and pharmaceutical services such as CROs and CDMOs. BroadOak typically invests in growth-stage companies, helping them scale through organic growth and strategic acquisitions. Their portfolio includes a wide range of companies that support the broader healthcare and biotechnology ecosystem. Founded in 2006, the firm operates from offices in Bethesda and San Francisco, leveraging deep industry expertise to support the expansion of middle-market healthcare companies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Broad Oak Partners.